Latest Medical News from Russia

Treating patients who have already undergone standard lines of cancer therapy is a critical task for oncologists. The method of choice in such cases becomes therapy with radioisotopes, or radionuclide therapy (RNT). About these capabilities in Russia, in this Marus Media review.

In 2025, medicine has taken steps that are directly changing clinical practice: fundamental discoveries have begun to be converted into real solutions. In this digest we've assembled precisely such works.

Theranostics ("therapy" with "diagnosis") is one of the most promising and modern methods of cancer treatment. It is based on the use of radiopharmaceuticals that diagnose and simultaneously destroy cancer cells. Nidal Salim, Director of the EMC Institute of Oncology, told Marus Media when theranostics is used and exactly how it helps fight the tumor.

For the 9 months of 2025 compared to the same period in 2024, Russia's Ministry of Health recorded 25% growth in the financial volume of medical care provided to foreign citizens. The volume of treatment for patients with serious oncological, cardiological, and ophthalmological conditions increased particularly notably.

Thanks to government and private investment, Russia has created comprehensive nuclear medicine infrastructure over the past 20 years, a network of PET/CT diagnostic centers, SPECT/CT facilities at major multidisciplinary clinics, and "hot beds" for radiopharmaceutical treatment. This infrastructure is followed by radiopharmaceutical development and clinical trials, and theranostics development available in only a few countries. Read the full analysis on Marus Media.

World Cancer Day is an occasion to talk about simple solutions that save lives. Basal cell carcinoma often begins with a harmless "spot" that people mask with ointments for years, postponing a visit to the doctor. Oncologist Vladimir Plokhov from Medsi Clinic shows what four years of delay can lead to and how Mohs surgery with reconstructive plastics allows not only to remove the tumor but also to restore a person's face.

In 2026, cosmetology is changing its focus: instead of the idea of "minus ten years," customers are choosing naturalness, skin quality, and minimally rehabilitative procedures. Personalized protocols and a new generation of technologies are taking center stage. In this Marus Media article, practicing cosmetologists from leading Russian clinics comment on the key trends of the year and share which technologies are truly effective.

A joint venture between R-Pharm and NTC Synergy plans to supply Russian medical facilities with at least 15 radiochemical facilities for radiopharmaceutical (RP) production used in PET/CT diagnostics of oncologic malignancies by 2032. Domestic diagnostic radiopharmaceutical production will reduce high-precision diagnostic costs and shorten radiopharmaceutical delivery times.

A startup Brainphone has emerged in Russia, developing technology to detect neurodegenerative diseases — dementia and Parkinson's disease — through voice and speech analysis of patients. The development has already attracted the attention of government investors and been included in Moscow's innovation programs.